Nephrocare Healt

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE428V01029
  • NSEID: NEPHROPLUS
  • BSEID: 544647
INR
658.30
16.4 (2.55%)
BSENSE

Nov 20

BSE+NSE Vol: 1.16 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.16 lacs (-37.49%) Volume

Shareholding (Sep 2026)

FII

11.73%

Held by 27 FIIs

DII

8.11%

Held by 9 DIIs

Promoter

58.31%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 5.21%

  • Poor long term growth as Net Sales has grown by an annual rate of 15.80% and Operating profit at -30.62% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 0 times
2

With ROE of -0.8, it has a Very Expensive valuation with a 6.6 Price to Book Value

 
3

Reducing Promoter Confidence

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 6,471 Cr (Small Cap)

stock-summary
P/E

51.00

stock-summary
Industry P/E

63

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.39

stock-summary
Return on Equity

-0.80%

stock-summary
Price to Book

6.47

Revenue and Profits:
Net Sales:
303 Cr
(Quarterly Results - Sep 2026)
Net Profit:
34 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.43%
0%
-2.43%
6 Months
7.15%
0%
7.15%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Nephrocare Healt for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Announcements stock-summary

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

20-Nov-2026 | Source : BSE

Pursuant to Reg 30 of the SEBI Listing Regulations we hereby inform that the Company has scheduled an investor conference call as per the disclosure annexed herewith.

Disclosure Under Regulation 30 Of The SEBI Listing Regulations - Grant Of Esops Under The Nephroplus Employee Stock Option Scheme 2026.

17-Nov-2026 | Source : BSE

We hereby inform that the Company has approved grant of ESOPs under the Scheme as per the disclosure annexed herewith.

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

17-Nov-2026 | Source : BSE

Pursuant to Reg 30 of SEBI Listing Regulations 2015 we hereby inform that the Company has approved allotment of 342130 equity shares of Rs. 2/- each pursuant to the exercise of stock options under NephroPlus ESOP Scheme 2011.

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
15.80%
EBIT Growth (5y)
-30.62%
EBIT to Interest (avg)
1.85
Debt to EBITDA (avg)
0.16
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
0.63
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
19.84%
ROCE (avg)
5.12%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
51
Industry P/E
63
Price to Book Value
6.56
EV to EBIT
202.39
EV to EBITDA
70.14
EV to Capital Employed
10.18
EV to Sales
9.82
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.03%
ROE (Latest)
-0.80%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
Bollinger Bands
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Bearish
Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 13 Schemes (3.93%)

FIIs

Held by 27 FIIs (11.73%)

Promoter with highest holding

Edoras Investment Holdings Pte Ltd (26.56%)

Highest Public shareholder

Polar Capital Funds Plc - Healthcare Opportunities (8.28%)

Individual Investors Holdings

8.7%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2026 is 3.64% vs 3.68% in Jun 2026",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2026 is 13.93% vs 15.34% in Jun 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'26",
        "Jun'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "176.58",
          "val2": "170.38",
          "chgp": "3.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "25.01",
          "val2": "24.15",
          "chgp": "3.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.67",
          "val2": "0.49",
          "chgp": "36.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "14.31",
          "val2": "12.56",
          "chgp": "13.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.16%",
          "val2": "14.17%",
          "chgp": "-0.01%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Nephrocare Healt"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Nephrocare Healt"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "629.74",
          "val2": "543.60",
          "chgp": "15.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "88.16",
          "val2": "94.89",
          "chgp": "-7.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "49.76",
          "val2": "14.30",
          "chgp": "247.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-8.06",
          "val2": "34.24",
          "chgp": "-123.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.00%",
          "val2": "17.46%",
          "chgp": "-3.46%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Sep'26 - QoQstock-summary
Sep'26
Jun'26
Change(%)
Net Sales
176.58
170.38
3.64%
Operating Profit (PBDIT) excl Other Income
25.01
24.15
3.56%
Interest
0.67
0.49
36.73%
Exceptional Items
0.00
0.00
Standalone Net Profit
14.31
12.56
13.93%
Operating Profit Margin (Excl OI)
14.16%
14.17%
-0.01%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2026 is 3.64% vs 3.68% in Jun 2026

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Sep 2026 is 13.93% vs 15.34% in Jun 2026

Annual Results Snapshot (Standalone) - Mar'26stock-summary
Mar'26
Mar'25
Change(%)
Net Sales
629.74
543.60
15.85%
Operating Profit (PBDIT) excl Other Income
88.16
94.89
-7.09%
Interest
49.76
14.30
247.97%
Exceptional Items
0.00
0.00
Standalone Net Profit
-8.06
34.24
-123.54%
Operating Profit Margin (Excl OI)
14.00%
17.46%
-3.46%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details